Tarsus Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 3.79 M | $310.37 M | 0.29% | 8.90% |
| RTW INVESTMENTS, LP | 02/17/2026 | 3.34 M | $273.10 M | 4.97% | 7.83% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 3.00 M | $245.97 M | 0.13% | 7.05% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 2.56 M | $209.79 M | -3.88% | 6.01% |
| VANGUARD GROUP INC | 01/29/2026 | 2.40 M | $196.48 M | 5.61% | 5.63% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 2.23 M | $182.60 M | -14.38% | 5.23% |
| MORGAN STANLEY | 02/13/2026 | 2.04 M | $167.10 M | 6.71% | 4.79% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 1.93 M | $158.06 M | 34.14% | 4.53% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.19 M | $97.32 M | -51.58% | 2.79% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.17 M | $96.00 M | 13.71% | 2.75% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 1.13 M | $92.34 M | -9.63% | 2.65% |
| INVESCO LTD. | 02/19/2026 | 1.01 M | $82.89 M | 8.04% | 2.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 947.76 K | $77.62 M | 0.35% | 2.22% |
| STATE STREET CORP | 02/13/2026 | 929.06 K | $76.07 M | -0.76% | 2.18% |
| LORD, ABBETT & CO. LLC | 02/13/2026 | 855.65 K | $70.06 M | -13.19% | 2.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 758.11 K | $62.07 M | 41.43% | 1.78% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/13/2026 | 728.64 K | $59.66 M | -37.59% | 1.71% |
| FMR LLC | 02/17/2026 | 647.11 K | $52.99 M | 2,860.13% | 1.52% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 615.16 K | $50.37 M | 2.82% | 1.44% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 584.69 K | $47.87 M | 100.00% | 1.37% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 518.78 K | $42.48 M | 14.56% | 1.22% |
| TORONTO DOMINION BANK | 02/17/2026 | 510.25 K | $41.78 M | -17.38% | 1.20% |
| CLEARBRIDGE INVESTMENTS, LLC | 02/11/2026 | 506.09 K | $41.44 M | -10.74% | 1.19% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 474.05 K | $38.82 M | -1.72% | 1.11% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 441.87 K | $36.18 M | 13.33% | 1.04% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/17/2026 | 436.58 K | $35.75 M | -21.81% | 1.02% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 401.24 K | $32.85 M | -23.17% | 0.94% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 378.70 K | $31.01 M | 11.05% | 0.89% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 356.11 K | $29.16 M | 74.30% | 0.84% |
| NORTHERN TRUST CORP | 02/17/2026 | 342.49 K | $28.04 M | -4.36% | 0.80% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 337.02 K | $27.59 M | 1,419.25% | 0.79% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 333.11 K | $27.28 M | 0.06% | 0.78% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 02/06/2026 | 332.45 K | $27.22 M | 24.28% | 0.78% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 328.87 K | $26.93 M | -3.70% | 0.77% |
| NUVEEN, LLC | 02/12/2026 | 322.53 K | $26.41 M | -2.47% | 0.76% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 260.34 K | $21.32 M | -9.71% | 0.61% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 250.00 K | $20.47 M | -16.67% | 0.59% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 200.00 K | $16.38 M | -20.00% | 0.47% |
| JANE STREET GROUP, LLC | 02/12/2026 | 184.30 K | $15.09 M | 100.00% | 0.43% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 173.28 K | $14.19 M | 66.91% | 0.41% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 161.83 K | $13.25 M | 61.83% | 0.38% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 154.40 K | $12.64 M | -21.98% | 0.36% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/17/2026 | 153.76 K | $12.59 M | 3.66% | 0.36% |
| CANADA PENSION PLAN INVESTMENT BOARD | 02/17/2026 | 151.10 K | $12.37 M | 15.08% | 0.35% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 01/15/2026 | 130.38 K | $10.53 M | 1.28% | 0.31% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 128.09 K | $10.49 M | -51.85% | 0.30% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 119.06 K | $9.75 M | 20.56% | 0.28% |
| JEFFERIES FINANCIAL GROUP INC. | 02/09/2026 | 118.81 K | $9.73 M | 5.08% | 0.28% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 118.23 K | $9.68 M | -35.90% | 0.28% |
| NORGES BANK | 02/10/2026 | 117.59 K | $9.63 M | 100.00% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tarsus Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 296 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals Inc. The most heavily invested institutionals were:
Assenagon Asset Management S.A.: 1.28 M
Nuveen, LLC: 315,290
Allspring Global Investments Holdings, LLC: 131,612
Bank of New York Mellon Corp: 106,782
UBS Group AG: 82,124
COMMONWEALTH EQUITY SERVICES, LLC: 80,892
103.39% of Tarsus Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 51.17 M shares in the last 24 months. This purchase volume represents approximately $3.81 B in transactions.